Angiopoietin-1 offers potential therapeutic benefits for vascular protection, though its use may be limited by deleterious effects such as pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Ang-1's vascular protection may be offset by pulmonary hypertension risk; leaves open safe therapeutic targeting pending human studies.
Brindle et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: